Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Safety and Efficacy of a Three-Dose Regimen of an Adenoviral HIV Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in HIV Uninfected South African Adults
This study has been suspended.
Study NCT00413725.   Last updated on May 16, 2008.
Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
Please refer to this study by its ClinicalTrials.gov identifier: NCT00413725
South Africa
Perinatal HIV Research Unit, Chris Hani Baragwanath Hospital
Johannesburg, South Africa
Aurum Institute for Health, KOSH District
Klerksdorp, South Africa
Cape Town HVTU
Mowbray, South Africa
Centre for the AIDS Program of Research in South Africa (CAPRISA)
Congella, South Africa
Medunsa HIV Research Unit
Medunsa, South Africa, 0204 SF
Sponsors and Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)
HIV Vaccine Trials Network
Study Chair: Glenda Gray, MD Chris Hani Baragwanath Hospital
Study Chair: James Kublin, MD, MPH Fred Hutchinson Cancer Research Center